HIV Funding Cuts Endanger South Africa’s Lenacapavir Rollout

Written by

in

,

A new report from the US non-profit Physicians for Human Rights (PHR) has issued a stark warning for the healthcare industry. Recent HIV Funding Cuts from the Trump administration are directly threatening South Africa’s ability to deploy lenacapavir. This twice-yearly injectable has been celebrated as a major breakthrough in HIV prevention. HIV Funding Cuts Threaten Life-Saving Healthcare Infrastructure The PHR…

Continue reading with a Health Matters subscription

Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

SubscribeLog in